Search research articles
Contact Us
Filters
Showing results (231-240 of 791) with videos related to
Page
of 80
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
May 15, 2012
A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities
Yiming Chen, Hagop Kantarjian, Zeev Estrov, et al.
Cancer
|
June 24, 2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen
Deborah Thomas, Susan O'Brien, Stefan Faderl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2009
Significance of increasing levels of minimal residual disease in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic response
Hagop M Kantarjian, Jianqin Shan, Daniel Jones, et al.
Leukemia & Lymphoma
|
June 20, 2007
Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System
Miloslav Beran, Sijin Wen, Yu Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia
Ahmed Awais, Constantine S Tam, Dimitrios Kontoyiannis, et al.
Cancer
|
March 29, 2002
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia
Srdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia
Moshe Talpaz, Ashok Rakhit, Karen Rittweger, et al.
Cancer
|
March 29, 2002
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia
Jorge Cortes, Deborah Thomas, Adan Rios, et al.
Blood
|
November 19, 2005
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
Deepa Sampath, Jorge Cortes, Zeev Estrov, et al.
Blood
|
September 5, 2009
The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up
Ravin J Garg, Hagop Kantarjian, Susan O'Brien, et al.
Page
of 80
Search research articles
Search
Showing results (231-240 of 791) with videos related to
Sort By:
Page
of 80
Clinical Lymphoma, Myeloma & Leukemia
|
May 15, 2012
A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities
Yiming Chen, Hagop Kantarjian, Zeev Estrov, et al.
Cancer
|
June 24, 2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen
Deborah Thomas, Susan O'Brien, Stefan Faderl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2009
Significance of increasing levels of minimal residual disease in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic response
Hagop M Kantarjian, Jianqin Shan, Daniel Jones, et al.
Leukemia & Lymphoma
|
June 20, 2007
Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System
Miloslav Beran, Sijin Wen, Yu Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia
Ahmed Awais, Constantine S Tam, Dimitrios Kontoyiannis, et al.
Cancer
|
March 29, 2002
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia
Srdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia
Moshe Talpaz, Ashok Rakhit, Karen Rittweger, et al.
Cancer
|
March 29, 2002
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia
Jorge Cortes, Deborah Thomas, Adan Rios, et al.
Blood
|
November 19, 2005
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
Deepa Sampath, Jorge Cortes, Zeev Estrov, et al.
Blood
|
September 5, 2009
The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up
Ravin J Garg, Hagop Kantarjian, Susan O'Brien, et al.
Page
of 80